Four genes showed a higher fusion rate in OAs included NAB2 (0.4% vs. 4.2%) and STAT6 (0.4% vs. 2.9%) in soft tissue sarcoma and FGFR3 (0.4% vs. 3.1%) and TACC3 (0 vs. 3.0%) in glioma. This evidence concerns the gene STAT6 and soft tissue sarcoma.